Head-to-head · Cost-Efficiency Index
Nova MD vs VevaRX
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Nova MD
Shoppers who want an explicit tirzepatide dose-titration schedule alongside tiered pricing.
Visit Nova MDVevaRX
Readers in one of the 36 states it names who will confirm the charge in writing before submitting an intake.
Visit VevaRXThe verdict
Nova MD and VevaRX tie on the Cost-Efficiency Index at 60/100, so neither wins outright on the numbers. For most shoppers we'd start with Nova MD (ranked #244, a hair above #251) — Shoppers who want an explicit tirzepatide dose-titration schedule alongside tiered pricing. But VevaRX is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Nova MD.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Nova MD | VevaRX |
|---|---|---|
| Cost-Efficiency Index | 60/100 | 60/100 |
| Semaglutide / mo | $175/mo (compounded) | $189/month month-to-month (the same page also prints $167/month and a $467 three-month total) |
| Tirzepatide / mo | $199/mo (compounded) | $155.67/mo equivalent — VevaRX bills $467 every three months on a three-month minimum and publishes no monthly plan |
| Semaglutide / yr (modeled) | $2,100 | $2,268 |
| Tirzepatide / yr (modeled) | $2,388 | $1,860 |
| Coverage | Coverage not published | 36 states |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #244 | #251 |
Nova MD
60/100Where the value is
- Full 1/3/6/12-month tirzepatide pricing ladder disclosed, down to $149/mo on the annual plan
- Explicit monthly dose-titration schedule published for tirzepatide (2.5mg to 15mg over 6 months) — more clinical detail than most competitors in this set show
- LegitScript verification badge present with a working link to legitscript.com
The tradeoffs
- No compounding pharmacy is named — only 'Licensed U.S. Pharmacy'
- No state-coverage list is published anywhere on the public site (checked homepage, medical-disclaimers, and refund-policy pages)
VevaRX
60/100Where the value is
- Enumerates the 36 states it serves by name rather than making an unqualified nationwide claim
- States what the tirzepatide price covers — the treatment, the supplies, the provider visit and two-to-three-day shipping
- Publishes a monthly semaglutide option alongside the quarterly plan, which its tirzepatide program does not offer
The tradeoffs
- The semaglutide page carries four prices, two of which belong to tirzepatide: $189 a month, $399 for three months, $167 a month and a $467 total
- The tirzepatide page's own arithmetic is wrong — it calls $467 over three months "equivalent to $149 per month", when it is $155.67, a figure the semaglutide page states correctly
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.